First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287
pubblicato in: Contemporary clinical trials communications
data di pubblicazione: 2019-07-10
argomento principale: phase I clinical trial, carcinoma adenoido-cistico, study protocol
Cita articoli
There is nothing here
Articolo - wd:Q90933074